6 January 2020 in Protein & Peptide Letters
: In this era of multi-drug resistance (MDR), antimicrobial peptides (AMPs) are one of the most promising classes of potential drug candidates to combat communicable as well as noncommunicable diseases such as cancers and diabetes. AMPs show a wide spectrum of biological activities which include antiviral, antifungal, anti-mitogenic, anticancer, and anti-inflammatory properties. Apart from these prospective therapeutic potentials, the AMPs can act as food preservatives and immune modulators. Therefore, AMPs have the potential to replace conventional drugs and may gain a significant global drug market share. Although several AMPs have shown therapeutic potential in vitro or in vivo, in most cases they have failed the clinical trial owing to various issues. In this review, we discuss in brief (i) molecular mechanisms of AMPs in various diseases, (ii) importance of AMPs in pharmaceutical industries, (iii) the challenges in using AMPs as therapeutics and how to overcome, (iv) available AMP therapeutics in market, and (v) AMPs under clinical trials. Here, we specifically focus on the therapeutic AMPs in the areas of dermatology, surgery, oncology and metabolic diseases.
7 December 2021 in Journal of Water and Health
The study aimed to examine the relationship between antibiotic resistance, biofilm formation and genes responsible for biofilm formation. Sixty-six Pseudomonas aeruginosa isolates were obtained from hospital wastewater and analyzed for their antibiotic resistance. Biofilm production among the isolates was tested by indirect quantification method crystal violet assay. Biofilm-associated genes among these isolates psl, alg, and pel were also checked. The maximum resistance was observed for ampicillins (88.24%) followed by nalidixic (83.82%), and nitrofurantoin (64.71%), respectively. Biofilm phenotypes are distributed in the following categories: high 39.39% (n = 26); moderate 57.57% (n = 38), and weak 3.0% (n = 2). Among the total isolates, biofilm-associated genes were detected in 84.84% (n = 56) of isolates and the remaining isolates 15.15% (n = 10) did not harbor any genes. In this study, pslB was the most predominant gene observed (71.21%, n = 47) followed by pslA (57.57%, n = 38), pelA (45.45%, n = 30), algD (43.93%, n = 29), and pelD (27.27%, n = 18), respectively. The present study reveals that the majority of the isolates are multidrug resistant being moderate and high biofilm formers. The study implies that biofilm acts as a machinery for bacteria to survive in the hospital effluent which is an antibiotic stress environment.
6 November 2024 in Journal of Pure and Applied Microbiology
Pyocyanin is a blue-green phenazine pigment synthesized by Pseudomonas aeruginosa that has significant biotechnological applications. The present study aims to investigate pyocyanin extracts of multi-drug resistant P. aeruginosa isolates sourced from hospital wastewater and evaluate their antimicrobial activity against a panel of clinically relevant pathogens such as Staphylococcus aureus, Salmonella typhi, Achromobacter xylosoxidans and Candida albicans. Nutrient broth and King’s A broth supplemented with 1% nutrient supplements such as rice water and groundnut cake powder were used as a production medium. Extracted pyocyanin was confirmed by FTIR analysis. The isolates P8 and P9 demonstrated of varying concentrations of pyocyanin in different media. Isolate P8 showed maximum pyocyanin production in King’s A broth compared to nutrient broth with pyocyanin yields 14.34 (µg/mL) and 5.63 (µg/mL), respectively, without the nutrient supplements. Preliminary antimicrobial activity of the pyocyanin extracts exhibited substantial inhibition of tested bacterial culture at a concentration of 25 mg/µl; however, did not show any antifungal activity against tested fungi.
23 January 2023 in Journal of Water and Health
MSManikeri Shraddha Suresh
The present study investigated the predatory efficacy of Bdellovibrio isolated from untreated hospital wastewater sources against human pathogens. Bdellovibrio is a Gram-negative, motile, uniflagellate predatory bacteria present in the environment, which directly predates on other bacteria, including human pathogens. In the present study, 30 hospital effluent samples were collected and screened for Bdellovibrio. A total of 11 Bdellovibrio isolates were obtained by the double-layer agar technique. All the isolates were identified by amplification of the 16S rDNA coding region using polymerase chain reaction (PCR) and confirmed as Bdellovibrio stolpii. The lytic activity of confirmed isolates was investigated against four Gram-negative bacteria Pseudomonas aeruginosa ADW44, Pseudomonas aeruginosa 27853(ATCC Strain), V. cholerae and Salmonella typhimurium of clinical origin obtained from the institutional repository. Among the 11 isolates, three Bdellovibrio isolates NBd1, YBd1 and RBd1 demonstrated the ability to prey upon the tested clinical isolates. To the best of our knowledge, this is the first report on the isolation of B. stolpii from hospital wastewater settings in India with broad and high bacteriolytic activity.
23 April 2025 in International Journal of Environmental Health Research
Multiple drug-resistant bacterial infections have led to an increasing need for an effective disease outbreak response system, such as the One Health platform. While interactions among humans, animals, and ecosystems are crucial and inevitable for survival, the intercommunity transfer of drug resistance genes and the resulting diseases are matters of concern. The concept of bacterial predation and its application in different fields have attracted interest as a natural alternative to traditional antibiotics. Bdellovibrio bacteriovorus, an obligate bacterial predator, preys on a wide range of other bacteria, regardless of their antibiotic resistance status. The present study reviews the potential ability of one of the best studied bacteria among the Bdellovibrio and Like Organisms (BALOs) group B. bacteriovorus, as a One Health solution for pathogen control, delving into its role in interconnected sectors of human, animal, and environmental health, highlighting its prospects as a significant contributor to the One Health approach. Although in vivo animal studies have demonstrated the safety and efficacy of B. bacteriovorus in reducing bacterial burdens in various infection models, clinical trials have not yet been conducted. Understanding the molecular bases of predatory strategies and clinical studies may help in the development of a revolutionary biocontrol agent, such as One Health Solution, for treating infections.
26 November 2025 in International Journal of Environmental Health Research
Polyhydroxyalkanoates (PHAs) are biodegradable polymers with immense potential as eco-friendly alternatives to conventional plastics. The study aimed to screen for PHA-producing bacteria in different soil samples and evaluating for their hydrocarbon utilization. In the present study, a total of 30 soil samples were collected from different sites, such as petrol bunk, sewage, and garden. Among the total bacterial isolates obtained, 30 showed positive PHA production by preliminary screening Sudan Black B, Nile blue, and Nile red staining techniques. Quantitative estimation of PHA was performed using a shake flask experiment in a minimal medium with an initial pH of 7, 10% (v/v) inoculum, 30°C, 170 rpm at 72 h. The isolate Bacillus subtilis PHAD13 produced the highest PHA 59% extracted by sodium hypochlorite method. Polymers from Bacillus amyloliquefaciens (PHAD7), Bacillus subtilis (PHAD13), Bacillus cereus (NS1), and Klebsiella sp. (NG5) were characterized by FT-IR analysis. GC-MS analysis revealed the presence of PHA copolymer, with tridecanoic acid (C13:0, MCL-PHA), and longer chain monomers (C15:0-C18:1, LCL-PHA); coexistence indicates heterogeneous monomer integration. The bacterial growth on Bushnell-Haas agar supplemented with spent engine oil demonstrated hydrocarbon tolerance indicating its bioremediation potential. The present study demonstrates the dual functional capability of Bacillus subtilis for bioplastic production and hydrocarbon degradation.